Search
for
Sort by
Research 391–420 of 1000+
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Idiopathic Hirsutism*
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Hirsutism: Diagnosis and management
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Polycystic ovary syndrome (PCOS)
- Redefining hormone resistance in prostate cancer
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Gender-Affirming Hormone Therapy for Transgender Females
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Fibromodulin-Deficiency Alters Temporospatial Expression Patterns of Transforming Growth Factor-β Ligands and Receptors during Adult Mouse Skin Wound Healing
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Acne in women
- Cardiometabolic profile of young women with hypoprolactinemia
- Gender-Affirming Hormone Therapy for Transgender Men
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Managing Polycystic Ovary Syndrome: A Cognitive Behavioral Strategy
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Polycystic ovarian syndrome
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Hirsutism: diagnosis and treatment
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates